E-LIB Suche - Ergebnisse für: Asao, Tetsuhiko

1

Real-World Data on Subsequent Therapy for First-Line Osimer..:

Nishioka, Naoya ; Imai, Hisao ; Endo, Masahiro...
Targeted Oncology. 19 (2024) 3 - p. 423-433 , 2024

Link: https://doi.org/10.1007/..

2

Phase II Study of Durvalumab Immediately after Completion o..:

Nakamichi, Shinji ; Kubota, Kaoru ; Misumi, Toshihiro...
Clinical Cancer Research. 30 (2024) 6 - p. 1104-1110 , 2024

Link: https://doi.org/10.1158/..

3

Prognostic impact of adjuvant therapy for cisplatin-unfit p..:

Noritake, Osamu ; Nakamura, Shota ; Kinoshita, Fumie...
Lung Cancer. 188 (2024) - p. 107470 , 2024

Link: https://doi.org/10.1016/..

4

Usefulness of Computed Tomography for Evaluating the Effect..:

Abe, Sumiko ; Yasuda, Mina ; Tobino, Kazunori...
Journal of Asthma and Allergy. 17 (2024) - p. 325-337 , 2024

Link: https://doi.org/10.2147/..

5

Trophoblast Cell Surface Antigen 2 Expression in Thymic Car..:

Kurokawa, Kana ; Asao, Tetsuhiko ; Hayashi, Takuo...
JTO Clinical and Research Reports. 5 (2024) 7 - p. 100693 , 2024

Link: https://doi.org/10.1016/..

6

Multicenter Pharmacokinetic and Pharmacodynamic Study of Pe..:

Yagishita, Shigehiro ; Yamanaka, Yuta ; Kurata, Takayasu...
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

7

Reconsidering the Cutoff Value for Sensitive and Refractory..:

Torasawa, Masahiro ; Horinouchi, Hidehito ; Nomura, Shogo...
Journal of Thoracic Oncology. 19 (2024) 2 - p. 325-336 , 2024

Link: https://doi.org/10.1016/..

8

Lymphangioleiomyomatosis as a potent lung cancer risk facto..:

Torasawa, Masahiro ; Shukuya, Takehito ; Uemura, Kohei...
Respirology. , 2024

Link: https://doi.org/10.1111/..

9

Risk and survival of patients with non-small cell lung canc..:

Asao, Tetsuhiko ; Shukuya, Takehito ; Uemura, Kohei...
Lung Cancer. 194 (2024) - p. 107894 , 2024

Link: https://doi.org/10.1016/..

10

Early Detection of Therapeutic Benefit from PD-1/PD-L1 Bloc..:

Xu, Shiting ; Miura, Keita ; Shukuya, Takehito...
Cancers. 15 (2023) 4 - p. 1170 , 2023

Link: https://doi.org/10.3390/..

11

Study Design and Rationale for Marble Study: A Phase II Tri..:

Asao, Tetsuhiko ; Shukuya, Takehito ; Mimori, Tomoyasu...
Clinical Lung Cancer. 24 (2023) 7 - p. e247-e253 , 2023

Link: https://doi.org/10.1016/..

12

Pneumonitis associated with pembrolizumab plus chemotherapy..:

Fujimoto, Daichi ; Miura, Satoru ; Tomii, Keisuke...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

13

Genomic profiling and metastatic risk in early-stage non–sm..:

Fick, Cameron N. ; Dunne, Elizabeth G. ; Lankadasari, Manendra B....
JTCVS Open. 16 (2023) - p. 9-16 , 2023

Link: https://doi.org/10.1016/..

14

CALML5 is a novel diagnostic marker for differentiating thy..:

Kanamori, Koichiro ; Suina, Kentaro ; Shukuya, Takehito...
Thoracic Cancer. 14 (2023) 12 - p. 1089-1097 , 2023

Link: https://doi.org/10.1111/..

15

Clinical characteristics of adrenal insufficiency induced b..:

Kurokawa, Kana ; Mitsuishi, Yoichiro ; Shimada, Naoko...
Thoracic Cancer. 14 (2022) 5 - p. 442-449 , 2022

Link: https://doi.org/10.1111/..